
TAU researcher harnesses targeted delivery of microRNAs to primary tumors in mice to block the movement of cancer
A new Tel Aviv University study finds that combining genetic therapy with…

A new Tel Aviv University study finds that combining genetic therapy with…

Cleveland Clinic and The Hebrew University of Jerusalem will begin a formal…

4P-Pharma has signed an exclusive license agreement with Aquitaine Science Transfert, for…
Rapid Medical, a company focused on the development of neurovascular interventional devices,…

In a landmark discovery, researchers at Tel Aviv University have unraveled the…